Lenacapavir HIV Prevention Injection to Reach Too Few

South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Uncontrolled Hypertension Plagues Millions in SA

Hypertension, or high blood pressure, has emerged as a significant public health crisis in South Africa. It silently affects millions and places immense strain on the nation’s healthcare system. With over 8.2 million individuals reported to be living with the condition, the prevalence rate is staggering. It is around 45% among men and 48% among…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here